Magnora ASA: Corrected Q4 2022 Presentation Read more about Magnora ASA: Corrected Q4 2022 Presentation
SmartCraft ASA (SMCRT) - Reminder: Invitation to presentation of fourth quarter 2022 results Read more about SmartCraft ASA (SMCRT) - Reminder: Invitation to presentation of fourth quarter 2022 results
Invitation to presentation of 4th quarter 2022 result Read more about Invitation to presentation of 4th quarter 2022 result
Pharnext refocuses its clinical trial programs on PXT3003, its most promising drug candidate, to optimize financial resources allocation Read more about Pharnext refocuses its clinical trial programs on PXT3003, its most promising drug candidate, to optimize financial resources allocation
SpareBank 1 Nord-Norge – buyback of outstanding AT1 (NONG95 PRO) Read more about SpareBank 1 Nord-Norge – buyback of outstanding AT1 (NONG95 PRO)
Treasure ASA: Initiating potential buy-back of own shares Read more about Treasure ASA: Initiating potential buy-back of own shares
Norsk Hydro: Unique position in a new reality Read more about Norsk Hydro: Unique position in a new reality
Airthings ASA: Mandatory notifications of trade Read more about Airthings ASA: Mandatory notifications of trade